Matches in Nanopublications for { ?s ?p "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP333289.RAi2cN9LCPJLiECkQNRhpT4R_JWCahZYVO6IAcgKXrYeM130_assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP333289.RAi2cN9LCPJLiECkQNRhpT4R_JWCahZYVO6IAcgKXrYeM130_provenance.
- assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP292879.RAnYEvYMB_0C-aHwoCIQw-hYIQT8uL1llrI_MHa--6E7g130_assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292879.RAnYEvYMB_0C-aHwoCIQw-hYIQT8uL1llrI_MHa--6E7g130_provenance.
- NP964044.RAK6fjyqEEiDAuleMeXROxlIQCsAuIVHXLkCVqTahZitU130_assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964044.RAK6fjyqEEiDAuleMeXROxlIQCsAuIVHXLkCVqTahZitU130_provenance.
- NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_assertion description "[Furthermore, MECOM mRNA and protein expression were repressed by imatinib mesylate treatment of CML-CP CD34(+) cells, K562 and KY01 cell lines whereas imatinib had no effect in non-CML BCR-ABL1 -ve CD34(+) cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP964046.RA6S9XBKsXeMZX_ujZciWDiWfhJQQX1MaimEHPJEv4ti4130_provenance.